

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 8.46351813 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.48387587 |
| 3 | glomerular filtration (GO:0003094) | 6.65955940 |
| 4 | protein activation cascade (GO:0072376) | 6.22834537 |
| 5 | renal filtration (GO:0097205) | 6.03683944 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.99051376 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.97006065 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.64889337 |
| 9 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.45341407 |
| 10 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.45341407 |
| 11 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.45341407 |
| 12 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.41774894 |
| 13 | regulation of respiratory burst (GO:0060263) | 5.04330411 |
| 14 | humoral immune response (GO:0006959) | 4.93966923 |
| 15 | detection of bacterium (GO:0016045) | 4.45442547 |
| 16 | antimicrobial humoral response (GO:0019730) | 4.38864414 |
| 17 | detection of other organism (GO:0098543) | 4.34436894 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32496025 |
| 19 | antibacterial humoral response (GO:0019731) | 4.30141176 |
| 20 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.95442818 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.90762273 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90762273 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.90629971 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.90629971 |
| 25 | response to type I interferon (GO:0034340) | 3.88872351 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.83697844 |
| 27 | retina homeostasis (GO:0001895) | 3.70518129 |
| 28 | germinal center formation (GO:0002467) | 3.68745686 |
| 29 | regulation of cellular extravasation (GO:0002691) | 3.62431253 |
| 30 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.53791065 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.49523329 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43442279 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24811450 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.23599958 |
| 35 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19412542 |
| 36 | cellular response to interferon-gamma (GO:0071346) | 3.18761253 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.18423528 |
| 38 | response to interferon-gamma (GO:0034341) | 2.97532373 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96233190 |
| 40 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95324162 |
| 41 | surfactant homeostasis (GO:0043129) | 2.94518580 |
| 42 | B cell mediated immunity (GO:0019724) | 2.92164575 |
| 43 | myeloid dendritic cell differentiation (GO:0043011) | 2.91750362 |
| 44 | negative regulation of myotube differentiation (GO:0010832) | 2.87236543 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87223963 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 2.87223963 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87223963 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87223963 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87223963 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 2.87223963 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.85356393 |
| 52 | immune response-activating signal transduction (GO:0002757) | 2.80497177 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80038113 |
| 54 | T-helper 1 type immune response (GO:0042088) | 2.79609177 |
| 55 | establishment of skin barrier (GO:0061436) | 2.76041364 |
| 56 | production of molecular mediator of immune response (GO:0002440) | 2.75957810 |
| 57 | detection of biotic stimulus (GO:0009595) | 2.74730413 |
| 58 | activation of immune response (GO:0002253) | 2.73572092 |
| 59 | regulation of water loss via skin (GO:0033561) | 2.72408361 |
| 60 | chronic inflammatory response (GO:0002544) | 2.71765252 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70859579 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 2.70585235 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65417929 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 2.64999901 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 2.64425176 |
| 66 | regulation of integrin activation (GO:0033623) | 2.62489975 |
| 67 | interferon-gamma secretion (GO:0072643) | 2.58772189 |
| 68 | dendritic cell chemotaxis (GO:0002407) | 2.56004444 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 2.51270333 |
| 70 | keratinization (GO:0031424) | 2.49743361 |
| 71 | T cell costimulation (GO:0031295) | 2.49433492 |
| 72 | lymphocyte costimulation (GO:0031294) | 2.45597324 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45007060 |
| 74 | negative regulation of bone resorption (GO:0045779) | 2.44859940 |
| 75 | respiratory burst (GO:0045730) | 2.43613114 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 2.42752450 |
| 77 | defense response to protozoan (GO:0042832) | 2.42513146 |
| 78 | regulation of tolerance induction (GO:0002643) | 2.41619414 |
| 79 | defense response to Gram-negative bacterium (GO:0050829) | 2.41292070 |
| 80 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.39833624 |
| 81 | negative regulation of humoral immune response (GO:0002921) | 2.38534176 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38119187 |
| 83 | positive regulation of T cell migration (GO:2000406) | 2.36862737 |
| 84 | positive regulation of pseudopodium assembly (GO:0031274) | 2.36522115 |
| 85 | positive thymic T cell selection (GO:0045059) | 2.35090625 |
| 86 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.34503680 |
| 87 | negative regulation of complement activation (GO:0045916) | 2.33794106 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.31825014 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.31486034 |
| 90 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.31368345 |
| 91 | positive regulation of B cell differentiation (GO:0045579) | 2.31219421 |
| 92 | multicellular organismal water homeostasis (GO:0050891) | 2.30851612 |
| 93 | cellular extravasation (GO:0045123) | 2.30306157 |
| 94 | response to interferon-beta (GO:0035456) | 2.30191651 |
| 95 | regulation of T cell migration (GO:2000404) | 2.29923122 |
| 96 | regulation of necrotic cell death (GO:0010939) | 2.29753957 |
| 97 | virion attachment to host cell (GO:0019062) | 2.29517954 |
| 98 | adhesion of symbiont to host cell (GO:0044650) | 2.29517954 |
| 99 | response to interleukin-15 (GO:0070672) | 2.28873519 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.6716958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.80571065 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.88224866 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.67341818 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65083156 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25606062 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.23278882 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.92533857 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82440132 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50467550 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47760462 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39752065 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25956300 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19975926 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14918526 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11850609 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07448812 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95290325 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91219006 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89753106 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85355022 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.83893481 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82145110 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81827999 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80541306 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76880519 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72181954 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69875708 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69388352 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67823996 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63310300 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62060851 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61531233 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.56731836 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53662399 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.52838005 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52326802 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51523103 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50265968 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.46844444 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42014028 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40330485 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39810494 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38934055 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35603898 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33640768 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.32575211 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32260986 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32104948 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31931185 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29491409 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27618814 |
| 52 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25938033 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24123816 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23205087 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22003844 |
| 56 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20881172 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20664239 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20535479 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16940108 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16727389 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16389867 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16167724 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16077752 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15871506 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15403467 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15374849 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12551050 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12342674 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10575500 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07934289 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04847275 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04732486 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04096297 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03937358 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03703050 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02409042 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00602119 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99366482 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98672965 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98113745 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96227806 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96017710 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95496301 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94984244 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94652889 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94628778 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94082557 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92086958 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90990094 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90990094 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88833040 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87676331 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.87343779 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86547865 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85899391 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84529740 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83593479 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80891107 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78852282 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78777540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.22843045 |
| 2 | MP0003303_peritoneal_inflammation | 3.60296737 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.25883868 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.13969427 |
| 5 | MP0003436_decreased_susceptibility_to | 3.13583198 |
| 6 | MP0001790_abnormal_immune_system | 2.99775682 |
| 7 | MP0005387_immune_system_phenotype | 2.99775682 |
| 8 | MP0000685_abnormal_immune_system | 2.73580867 |
| 9 | MP0001800_abnormal_humoral_immune | 2.70946142 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.67506211 |
| 11 | MP0005275_abnormal_skin_tensile | 2.65577360 |
| 12 | MP0005025_abnormal_response_to | 2.46285799 |
| 13 | MP0005671_abnormal_response_to | 2.43904712 |
| 14 | MP0009785_altered_susceptibility_to | 2.40243136 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.32888186 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.27443590 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.20756229 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.13517575 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.01224044 |
| 20 | MP0004947_skin_inflammation | 2.01198630 |
| 21 | MP0002723_abnormal_immune_serum | 2.00268262 |
| 22 | MP0002796_impaired_skin_barrier | 1.99597380 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 1.97573510 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.95999925 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.95954797 |
| 26 | MP0002419_abnormal_innate_immunity | 1.93604236 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.93549606 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.90909805 |
| 29 | MP0001819_abnormal_immune_cell | 1.89338300 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.88330761 |
| 31 | MP0005166_decreased_susceptibility_to | 1.84762491 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.84062082 |
| 33 | MP0003866_abnormal_defecation | 1.81632618 |
| 34 | MP0001873_stomach_inflammation | 1.71496632 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.70683067 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.70022316 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.62836724 |
| 38 | MP0006082_CNS_inflammation | 1.58849285 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.48621084 |
| 40 | MP0002006_tumorigenesis | 1.44739598 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.44432192 |
| 42 | MP0004858_abnormal_nervous_system | 1.40177724 |
| 43 | MP0000716_abnormal_immune_system | 1.39303712 |
| 44 | MP0005023_abnormal_wound_healing | 1.37666497 |
| 45 | MP0003448_altered_tumor_morphology | 1.36781808 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.35538879 |
| 47 | MP0002398_abnormal_bone_marrow | 1.32589956 |
| 48 | MP0008004_abnormal_stomach_pH | 1.31052725 |
| 49 | MP0000858_altered_metastatic_potential | 1.29692333 |
| 50 | MP0003075_altered_response_to | 1.28192940 |
| 51 | MP0005310_abnormal_salivary_gland | 1.27534325 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.25738687 |
| 53 | MP0003045_fibrosis | 1.24499424 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.23779746 |
| 55 | MP0001663_abnormal_digestive_system | 1.23093731 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.21563304 |
| 57 | MP0002405_respiratory_system_inflammati | 1.20705061 |
| 58 | MP0005503_abnormal_tendon_morphology | 1.19208971 |
| 59 | MP0000343_altered_response_to | 1.17443966 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.10228719 |
| 61 | MP0002429_abnormal_blood_cell | 1.08895924 |
| 62 | MP0001851_eye_inflammation | 1.08024373 |
| 63 | MP0000604_amyloidosis | 1.05773247 |
| 64 | MP0003828_pulmonary_edema | 1.05427593 |
| 65 | MP0001216_abnormal_epidermal_layer | 1.05421193 |
| 66 | MP0008469_abnormal_protein_level | 1.05082138 |
| 67 | MP0002933_joint_inflammation | 1.04785310 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.02745829 |
| 69 | MP0005164_abnormal_response_to | 1.02601814 |
| 70 | MP0005390_skeleton_phenotype | 1.02127034 |
| 71 | MP0003279_aneurysm | 1.02002892 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.01404077 |
| 73 | MP0000477_abnormal_intestine_morphology | 0.98173007 |
| 74 | MP0002722_abnormal_immune_system | 0.97878024 |
| 75 | MP0000490_abnormal_crypts_of | 0.96879172 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.95842187 |
| 77 | MP0002060_abnormal_skin_morphology | 0.95820948 |
| 78 | MP0009840_abnormal_foam_cell | 0.92277989 |
| 79 | MP0009764_decreased_sensitivity_to | 0.91180621 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.88692528 |
| 81 | MP0000249_abnormal_blood_vessel | 0.88540372 |
| 82 | MP0003329_amyloid_beta_deposits | 0.86467047 |
| 83 | MP0003091_abnormal_cell_migration | 0.86349176 |
| 84 | MP0005451_abnormal_body_composition | 0.85285772 |
| 85 | MP0005501_abnormal_skin_physiology | 0.83142508 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.82688966 |
| 87 | MP0003868_abnormal_feces_composition | 0.79160479 |
| 88 | MP0000579_abnormal_nail_morphology | 0.78209228 |
| 89 | MP0009278_abnormal_bone_marrow | 0.77806408 |
| 90 | MP0003795_abnormal_bone_structure | 0.77769224 |
| 91 | MP0002133_abnormal_respiratory_system | 0.77546073 |
| 92 | MP0005388_respiratory_system_phenotype | 0.77546073 |
| 93 | MP0005409_darkened_coat_color | 0.76205961 |
| 94 | MP0008260_abnormal_autophagy | 0.75633418 |
| 95 | MP0004510_myositis | 0.74498200 |
| 96 | MP0009931_abnormal_skin_appearance | 0.73496831 |
| 97 | MP0005165_increased_susceptibility_to | 0.72953624 |
| 98 | MP0001666_abnormal_nutrient_absorption | 0.72143547 |
| 99 | MP0001664_abnormal_digestion | 0.67978723 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.67263898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 5.68542617 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.39339524 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.79546841 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.45576854 |
| 5 | Increased IgE level (HP:0003212) | 4.19081259 |
| 6 | Abnormality of the prostate (HP:0008775) | 3.97843106 |
| 7 | Vasculitis (HP:0002633) | 3.90227916 |
| 8 | Alopecia of scalp (HP:0002293) | 3.75172766 |
| 9 | Abnormality of complement system (HP:0005339) | 3.62819022 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.55573516 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 3.55355519 |
| 12 | Malnutrition (HP:0004395) | 3.45553864 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.45509455 |
| 14 | Glomerulonephritis (HP:0000099) | 3.38596517 |
| 15 | Complement deficiency (HP:0004431) | 3.31019878 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.28100663 |
| 17 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.18860865 |
| 18 | Premature loss of primary teeth (HP:0006323) | 3.18827273 |
| 19 | Colitis (HP:0002583) | 3.11974493 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.07179715 |
| 21 | Meningitis (HP:0001287) | 3.05128404 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.00367499 |
| 23 | Urticaria (HP:0001025) | 2.98409330 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96291790 |
| 25 | Cellulitis (HP:0100658) | 2.94376288 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 2.92803186 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.88411170 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.88279523 |
| 29 | Leukocytosis (HP:0001974) | 2.87543899 |
| 30 | Abnormality of nail color (HP:0100643) | 2.85467272 |
| 31 | Skin rash (HP:0000988) | 2.85320653 |
| 32 | Nephritis (HP:0000123) | 2.83064914 |
| 33 | Gingivitis (HP:0000230) | 2.77556664 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.75799032 |
| 35 | Thick nail (HP:0001805) | 2.68502015 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 2.67551095 |
| 37 | Recurrent viral infections (HP:0004429) | 2.64977980 |
| 38 | Osteomyelitis (HP:0002754) | 2.64910037 |
| 39 | Myositis (HP:0100614) | 2.62402597 |
| 40 | Emphysema (HP:0002097) | 2.58391083 |
| 41 | Chronic otitis media (HP:0000389) | 2.56461940 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.55548281 |
| 43 | Orchitis (HP:0100796) | 2.55180892 |
| 44 | Pustule (HP:0200039) | 2.53204271 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.50713360 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 2.49547284 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.48736794 |
| 48 | Recurrent sinusitis (HP:0011108) | 2.45437498 |
| 49 | Hemoptysis (HP:0002105) | 2.44672696 |
| 50 | Xerostomia (HP:0000217) | 2.43457401 |
| 51 | Chronic diarrhea (HP:0002028) | 2.43234449 |
| 52 | Palmoplantar hyperkeratosis (HP:0000972) | 2.39470870 |
| 53 | Onycholysis (HP:0001806) | 2.38130149 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.35978646 |
| 55 | Abnormality of male internal genitalia (HP:0000022) | 2.33851237 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.32545963 |
| 57 | Recurrent skin infections (HP:0001581) | 2.31560933 |
| 58 | Skin ulcer (HP:0200042) | 2.30129383 |
| 59 | Villous atrophy (HP:0011473) | 2.29607323 |
| 60 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.29607323 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29160023 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.27461379 |
| 63 | Plantar hyperkeratosis (HP:0007556) | 2.26307886 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25745545 |
| 65 | Palmar hyperkeratosis (HP:0010765) | 2.21300546 |
| 66 | Bronchitis (HP:0012387) | 2.20524001 |
| 67 | Obstructive lung disease (HP:0006536) | 2.17733885 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17733885 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.14826073 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.13821038 |
| 71 | Hypermelanotic macule (HP:0001034) | 2.13382224 |
| 72 | Neoplasm of the lung (HP:0100526) | 2.12108584 |
| 73 | Periodontitis (HP:0000704) | 2.12079959 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.11950306 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 2.11263432 |
| 76 | Optic neuritis (HP:0100653) | 2.11263432 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10772322 |
| 78 | Fragile skin (HP:0001030) | 2.09942176 |
| 79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07673015 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07673015 |
| 81 | Recurrent pneumonia (HP:0006532) | 2.06082620 |
| 82 | Restrictive lung disease (HP:0002091) | 2.04942436 |
| 83 | Atrophic scars (HP:0001075) | 2.04643086 |
| 84 | Verrucae (HP:0200043) | 2.04264813 |
| 85 | Papilloma (HP:0012740) | 2.04264813 |
| 86 | B lymphocytopenia (HP:0010976) | 2.04011157 |
| 87 | Erythema (HP:0010783) | 2.03861670 |
| 88 | Abnormal hair laboratory examination (HP:0003328) | 2.02450309 |
| 89 | Ankyloglossia (HP:0010296) | 1.99665175 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.99511458 |
| 91 | Nasal polyposis (HP:0100582) | 1.99024021 |
| 92 | Increased IgM level (HP:0003496) | 1.98974227 |
| 93 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98360131 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 1.96638704 |
| 95 | Gangrene (HP:0100758) | 1.95738654 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.94124378 |
| 97 | Lymphopenia (HP:0001888) | 1.91968874 |
| 98 | Sepsis (HP:0100806) | 1.91684991 |
| 99 | Chest pain (HP:0100749) | 1.90886570 |
| 100 | Ridged nail (HP:0001807) | 1.89507477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.47431602 |
| 2 | TYK2 | 3.45435475 |
| 3 | MAP4K1 | 3.42540226 |
| 4 | PRPF4B | 3.25813131 |
| 5 | FGFR4 | 3.11561990 |
| 6 | RIPK4 | 3.04165918 |
| 7 | MST1R | 2.94901368 |
| 8 | BLK | 2.67894578 |
| 9 | EPHA3 | 2.39098873 |
| 10 | RIPK1 | 2.37076277 |
| 11 | JAK1 | 2.25770471 |
| 12 | MAP3K14 | 2.19524939 |
| 13 | EPHB1 | 2.10094353 |
| 14 | KIT | 2.05482290 |
| 15 | FGFR3 | 1.97995540 |
| 16 | CDC42BPA | 1.90305381 |
| 17 | IKBKE | 1.89394319 |
| 18 | JAK3 | 1.84743867 |
| 19 | TBK1 | 1.61047219 |
| 20 | IRAK4 | 1.57153205 |
| 21 | CSK | 1.54617427 |
| 22 | ZAP70 | 1.53476425 |
| 23 | PIK3CA | 1.51858865 |
| 24 | STK24 | 1.44365144 |
| 25 | GRK6 | 1.38179565 |
| 26 | FES | 1.35537942 |
| 27 | EPHA2 | 1.32028371 |
| 28 | MAP3K13 | 1.28643717 |
| 29 | SIK3 | 1.28333379 |
| 30 | JAK2 | 1.27629117 |
| 31 | TXK | 1.25625319 |
| 32 | MAP3K1 | 1.24314395 |
| 33 | SYK | 1.21337113 |
| 34 | LYN | 1.19148936 |
| 35 | IRAK1 | 1.14609629 |
| 36 | PDGFRA | 1.14369752 |
| 37 | TGFBR1 | 1.14024128 |
| 38 | CSF1R | 1.13869051 |
| 39 | MAP3K10 | 1.04470900 |
| 40 | MATK | 1.04409399 |
| 41 | TRIB3 | 1.03767771 |
| 42 | FER | 1.02576848 |
| 43 | BMPR2 | 1.02062317 |
| 44 | MAP3K3 | 0.96025592 |
| 45 | BTK | 0.93222049 |
| 46 | HCK | 0.91504596 |
| 47 | YES1 | 0.90141580 |
| 48 | MET | 0.89657805 |
| 49 | SMG1 | 0.87849790 |
| 50 | TAOK1 | 0.87523299 |
| 51 | IKBKB | 0.86634512 |
| 52 | NLK | 0.86523845 |
| 53 | DDR2 | 0.85572656 |
| 54 | PKN2 | 0.83869968 |
| 55 | MAPK7 | 0.81968659 |
| 56 | FGR | 0.81040088 |
| 57 | PTK6 | 0.78376025 |
| 58 | RET | 0.72534129 |
| 59 | LCK | 0.72097169 |
| 60 | TGFBR2 | 0.71577588 |
| 61 | MAP3K6 | 0.70664312 |
| 62 | TAOK3 | 0.69615398 |
| 63 | NEK9 | 0.68126608 |
| 64 | MAP2K3 | 0.67871833 |
| 65 | HIPK2 | 0.64660959 |
| 66 | ACVR1B | 0.62571156 |
| 67 | LRRK2 | 0.61811193 |
| 68 | PRKG2 | 0.61470139 |
| 69 | DMPK | 0.60444104 |
| 70 | EIF2AK3 | 0.56922386 |
| 71 | FYN | 0.56832661 |
| 72 | PDPK1 | 0.55310280 |
| 73 | CDK6 | 0.55151095 |
| 74 | EPHB2 | 0.54687092 |
| 75 | KSR2 | 0.52192211 |
| 76 | PDGFRB | 0.49670212 |
| 77 | MAPKAPK2 | 0.49519258 |
| 78 | MAP3K2 | 0.49414952 |
| 79 | PDK1 | 0.48385553 |
| 80 | MAPK11 | 0.48256556 |
| 81 | IRAK3 | 0.47895442 |
| 82 | LMTK2 | 0.46485414 |
| 83 | ITK | 0.43661056 |
| 84 | PAK4 | 0.42545764 |
| 85 | MYLK | 0.41026110 |
| 86 | PRKD2 | 0.38680795 |
| 87 | TAOK2 | 0.37872740 |
| 88 | PRKCQ | 0.35918249 |
| 89 | MAPK4 | 0.32970490 |
| 90 | PRKCD | 0.31407927 |
| 91 | TEC | 0.31239050 |
| 92 | MAPK12 | 0.30618683 |
| 93 | ABL1 | 0.30490813 |
| 94 | IGF1R | 0.29123351 |
| 95 | TNK2 | 0.27027751 |
| 96 | SIK2 | 0.25559996 |
| 97 | SRC | 0.25048109 |
| 98 | MAP3K5 | 0.22901748 |
| 99 | CHUK | 0.22868604 |
| 100 | MAP3K11 | 0.22120305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.72225017 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.36126327 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.33130103 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.20591571 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.08536563 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.01086751 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69719606 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.53367454 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31744494 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22989908 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01597209 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.98116953 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90147286 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76999454 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71077351 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.65998241 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65309596 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.63379521 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.56553114 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49458459 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41491502 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35021550 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32699681 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.27553006 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22301609 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22201863 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.21667459 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.18822980 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17219844 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17079443 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15045960 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.14982051 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14204473 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08727114 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08492150 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07261058 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04336520 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94069708 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93851641 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93390248 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92774290 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89659302 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89072549 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.87767260 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87367282 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87285376 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79495105 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79037907 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78140506 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77463329 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74973192 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72622385 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72277669 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.71627795 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70974961 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68092467 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.67858826 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67031280 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65677171 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.58624088 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.58490479 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58197233 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57423633 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57320773 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55860430 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.55038877 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.54886339 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54545719 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53488179 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51774941 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51468249 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50491636 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49700982 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49568116 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49449330 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47786024 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47157035 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46379615 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46078100 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.44969181 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.44445953 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42580363 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.41890249 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41052995 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40889522 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38882740 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38256823 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34960862 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34636421 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34148191 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33919387 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31754971 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31524459 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30673593 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29644100 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.28960104 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28178258 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28092742 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27865819 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27817328 |

